Jan. 18, 2022 – When Ellen Eaton, M.D., reflects on how important the 340B drug pricing program is to her patients living with HIV, one of the first people she thinks about is a woman she calls “Linda.” For many years, Linda struggled with substance use disorders. She lost custody of her children, was estranged from her family, had no income, and she was living without stable … [Read more...]
More Court Battles Ahead for 340B in 2022
Jan. 12, 2022– The dispute between safety-net hospitals and a growing group of drug companies over community-based pharmacies in the 340B drug pricing program is heading into a new phase of legal wrangling that ensures this fight will remain a dominant issue in the 340B world for months to come. As 2021 ended, two industry giants – Amgen and AbbVie – joined the group of … [Read more...]
Recapping a Momentous Year for 340B
Dec. 31, 2021– Today is the final day of what might be one of the most eventful years in the history of the 340B drug pricing program. Key developments in the 340B world stood out even amid all the news about a global pandemic, a change in leadership in Washington, and an uneasy economic climate. As we wrap up 2021 and look forward to a new year, we are reflecting on some of … [Read more...]
A Hospital Community United Against Threats to 340B
Dec. 20, 2021— Hundreds of safety-net hospitals are urging the federal government to escalate its efforts to stop a group of drug companies that are refusing to offer drug discounts that the federal 340B drug pricing program requires. Today, more than 800 hospitals participating in 340B sent a letter to Health and Human Services (HHS) Secretary Xavier Becerra calling on the … [Read more...]
Meet Some of the 340B Program’s Top Champions
Dec. 17, 2021— The success of the 340B drug pricing program in providing crucial care to those in need is backed up by both a growing body of research and the personal testimonials of patients and health care providers. Behind that success are dedicated professionals who help ensure that safety-net hospitals run effective, efficient, and compliant 340B programs. Throughout … [Read more...]
340B Transparency Efforts Uncovering More Drug Company Overcharges
Dec. 8, 2021– In the nearly three years since the Health Resources & Services Administration (HRSA) launched its 340B drug pricing program ceiling price website, 41 drug companies have acknowledged that they overcharged 340B hospitals, health centers, and clinics and would refund those affected. This contrasts with only seven such reports in the two years prior to the … [Read more...]
We Celebrate Rural Health Day by Protecting 340B
Nov. 18, 2021– The patient care mission of 340B hospitals serving rural areas of the U.S. takes on a special importance when one considers that in many cases, they are the only providers in a position to offer certain types of needed care. On this National Rural Health Day, we reflect on the crucial nature of the role rural hospitals play, the continuing challenges they face, … [Read more...]